CRISPR/Cas9 can successfully edit multiple gliadin genes in bread wheat, representing a step towards developing hypoimmunogenic wheat for coeliac disease.
Supports hypoimmunogenic wheat breeding for coeliac disease; leaves open field translation and regulatory evaluation.
The results demonstrate the feasibility and efficacy of using CRISPR/Cas9 to simultaneously edit multiple genes in the large α- and γ-gliadin gene families in polyploid bread wheat. Additional methods, generating genomics and proteomics data, will be necessary to determine the exact nature of the mutations generated with both methods.
No takes yet. Share an insight, caveat, or question.
Jouanin et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: